YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Procrit
Proposed Aranesp, Epogen, Procrit Dosage Limit Rejected by FDA Advisory Panel
Sep 12, 2007 | Parker Waichman Alonso, LLP
An advisory panel has concluded that Amgen's anemia medications should not be subject to a new dosage limit proposed by the Food & Drug...
Controversy over Aranesp, Epogen and Procrit to Be Addressed by FDA Panel
Sep 10, 2007 | Parker Waichman Alonso, LLP
Aranesp, Epogen and Procrit, drugs given to anemia patients suffering end-stage kidney failure, will be taken up by a Food & Drug Administration...
FDA Panel Highlights Safety Concerns of Anemia Drugs in Cancer Patients
May 11, 2007 | Newsinferno.com
In a high-profile meeting this week, an expert panel of the U.S. Food and Drug Administration (FDA) raised significant concerns about the use of the...
FDA panel wants more anemia drug studies
May 10, 2007 | AP
Two months after federal regulators ordered additional warnings be added to the labels of blockbuster anemia drugs, government advisers said Thursday...
FDA issues new warnings on anemia drugs
Mar 9, 2007 | AP
Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk...
FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)
Mar 9, 2007 | www.fda.gov
The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product...
FDA Warns of Serious Side Effects Related to Popular Anemia Drugs
Mar 9, 2007 | NewsInferno.com
FDA Warns of Serious Side Effects Related to Popular Anemia DrugsThe U.S. Food and Drug Administration (FDA) has issued a new warning about...
Anemia Drugs Procrit & Epogen May Do More Harm Than Good
Nov 30, 2006 | Newsinferno.com
Two studies in the New England Journal of Medicine this month have called into question the overuse of drugs in the treatment of anemia in kidney...
Defective Drugs
